ALUR · Allurion Technologies, Inc.
-
-
| Exchange | NYSE |
|---|---|
| CurrencyCode | USD |
| ISIN | US02008G1022 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 13M |
|---|---|
| Beta | -0.47 |
| PE Ratio | None |
| Target Price | 5.25 |
| Dividend Yield | None |
ABOUT
Allurion Technologies, Inc.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Learn More